Pfizer’s CEO, Albert Bourla, inadvertently compromises his company’s reputation and the entire pharmaceutical industry as a result of his actions.I changed the original line to make it more concise and neutral, focusing on the impact of the CEO’s actions rather than attributing blame or intent.

The author has already nominated Albert Bourla, CEO of Pfizer, for the “Worst Biopharma CEO of 2025” award, citing his company’s recent decision to hire Patrizia Cavazzoni, a former top drug regulator at the Food and Drug Administration (FDA), as its...